Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vulvar Neoplasms × DNA × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Vulvar Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Metabolic Syndrome 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Disease 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 3 Surgical Procedures, Operative 2 trastuzumab deruxtecan 1 Watchful Waiting 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 RNA 1 Psychiatric Rehabilitation 1 Observation 1 Multimodal Imaging 1 Indocyanine Green 1 Immunohistochemistry 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Drug Therapy 1 DNA 1 Circulating Tumor DNA 1 CA-125 Antigen 1 Buthionine Sulfoximine 1 Brachytherapy 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06582108 2024-09-03

ROAR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡